It's painfully obviousNot one of the criers and self appointed experts on this board have any idea of what it takes for a small company to get to where PLI is today in terms of FDA, research and development. If PLI was a mega pharma things might be smoother and that is refelected in sp, hence where the opportunity lays. I'm looking forward to adding to my holdings when sp settles.